Christopher Pearce serves as Executive at TNI BIOTECH, INC., where they oversee executive responsibilities. Since joining the company, Christopher Pearce has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 18, 2016 involved transacting 1,000,000 shares valued at $0.
Christopher Pearce currently holds 2,876,125 shares of TNI BIOTECH, INC. (TNIB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Pearce has been a net neutral trader of TNIB stock. They have purchased $0 and sold $0 worth of shares.
Christopher Pearce's most recent insider trade was on Jul 18, 2016, when they sold 1,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 31, 2015 | IMUN | $0 | Other | 1,200,000 | $N/A | Discretionary |
| Sep 17, 2015 | IMUN | $0 | Other | 1,300,000 | $N/A | Discretionary |
| Sep 2, 2015 | IMUN | $0 | Other | 1,200,000 | $N/A | Discretionary |
| Jan 8, 2015 | IMUN | $0 | Other | 200,000 | $N/A | Discretionary |
| Dec 23, 2014 | IMUN | $0 | Other | 33,125 | $N/A | Discretionary |
| Nov 25, 2014 | IMUN | $0 | Other | 500,000 | $N/A | Discretionary |
| Nov 25, 2014 | IMUN | $0 | Award | 25,000 | $N/A | Discretionary |
| Sep 30, 2014 | TNIB | $0 | Other | 500,000 | $N/A | Discretionary |
| Apr 16, 2014 | IMUN | $0 | Award | 0 | $N/A | Discretionary |